Wordt geladen...
A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells
To harness the potent tumor-killing capacity of T cells for the treatment of CD19(+) malignancies, we constructed AFM11, a humanized tetravalent bispecific CD19/CD3 tandem diabody (TandAb) consisting solely of Fv domains. The molecule exhibits good manufacturability and stability properties. AFM11 h...
Bewaard in:
| Gepubliceerd in: | MAbs |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4622993/ https://ncbi.nlm.nih.gov/pubmed/25875246 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2015.1029216 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|